- Home
- TYL vs PODD Comparison
TYL vs PODD Comparison
Compare TYL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYL
- PODD
- Stock Information
- Founded
- TYL 1966
- PODD 2000
- Country
- TYL United States
- PODD United States
- Employees
- TYL N/A
- PODD N/A
- Industry
- TYL Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- TYL Technology
- PODD Health Care
- Exchange
- TYL Nasdaq
- PODD Nasdaq
- Market Cap
- TYL 25.0B
- PODD 21.5B
- IPO Year
- TYL N/A
- PODD 2007
- Fundamental
- Price
- TYL $554.51
- PODD $290.28
- Analyst Decision
- TYL Buy
- PODD Strong Buy
- Analyst Count
- TYL 12
- PODD 19
- Target Price
- TYL $680.50
- PODD $320.11
- AVG Volume (30 Days)
- TYL 304.6K
- PODD 781.9K
- Earning Date
- TYL 07-23-2025
- PODD 08-07-2025
- Dividend Yield
- TYL N/A
- PODD N/A
- EPS Growth
- TYL 50.34
- PODD 67.46
- EPS
- TYL 6.63
- PODD 5.55
- Revenue
- TYL $2,190,609,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- TYL $10.16
- PODD $24.49
- Revenue Next Year
- TYL $9.72
- PODD $17.45
- P/E Ratio
- TYL $83.25
- PODD $52.14
- Revenue Growth
- TYL 9.96
- PODD 23.48
- 52 Week Low
- TYL $509.19
- PODD $173.00
- 52 Week High
- TYL $661.31
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- TYL 36.98
- PODD 36.89
- Support Level
- TYL $572.27
- PODD $293.38
- Resistance Level
- TYL $595.21
- PODD $300.00
- Average True Range (ATR)
- TYL 11.96
- PODD 7.24
- MACD
- TYL -3.47
- PODD -1.88
- Stochastic Oscillator
- TYL 2.20
- PODD 6.98
About TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.